PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in Australia

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Major Depressive Disorder

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2018English

Major Depressive Disorder

English

Major Depressive Disorder

2013English

Epigenetic Aging in Major Depressive Disorder

American Journal of Psychiatry
PsychiatryMental Health
2018English

Neurobiological Mechanisms in Major Depressive Disorder

CMAJ
Medicine
2009English

Venlafaxine Versus Sertraline for Major Depressive Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2000English

Development and Evaluation of a Multimodal Marker of Major Depressive Disorder

Human Brain Mapping
Nuclear MedicineRadiologyUltrasound TechnologyAnatomyRadiologicalNeurologyImaging
2018English

Temperament and Major Depressive Disorder

Annals of General Psychiatry
PsychiatryMental Health
2010English

Subcortical Brain Alterations in Major Depressive Disorder: Findings From the ENIGMA Major Depressive Disorder Working Group

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy